Company Overview and News

 
Itz Cash parent acquires Paul Merchants to become largest money transfer firm in India

2017-09-21 livemint
Mumbai: Ebix Inc., the parent firm of digital payments company Itz Cash Card Ltd, has acquired the money transfer business of Paul Merchants Ltd through its Indian affiliate, the firms said on Thursday. The deal, valued at $40.7 million, is a slump sale, Paul Merchants said in a note to stock exchanges.
Upvote Downvote

 
Board of Paul Merchants approves slump sale of MTSS business in India

2017-09-21 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication.
Upvote Downvote

 
Nasdaq-listed Ebix Inc acquires Paul Merchants' international remittance biz

2017-09-21 thehindubusinessline
This is the third acquisition by Ebix Inc in the last two months in the international remittance segment, giving it a 60 per cent market share and leadership position in this segment in India.
Upvote Downvote

 
Euronet Worldwide's (EEFT) CEO Mike Brown on Q2 2017 Results - Earnings Call Transcript

2017-07-26 seekingalpha
Greetings and welcome to the Euronet Worldwide Second Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference call maybe recorded. It is now my pleasure to introduce your host Mr. Jeff Newman, Executive Vice President and General Counsel for Euronet Worldwide. Thank you, Mr. Newman. You may begin.
Upvote Downvote

 
Four stocks to watch out for today

2017-01-06 indiainfoline
Watch out for these four stocks in today’s trade: Majesco, Paul Merchants, Videocon Industries and Mastek Limited
Upvote Downvote

 
PIMCO Municipal Income Fund Form N-CSRS

2015-12-30 sec.gov
PIMCO Municipal Income Fund Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-CSR CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES Investment Company Act file number: 811-10377 PIMCO Municipal Income Fund (Exact name of registrant as specified in charter) 1633 Broadway, New York, NY 10019 (Address of principal executive offices) William G.
Upvote Downvote

 
What The 'Junk-Bond Crisis' Means For Muni Bonds

2015-12-01 seekingalpha
High-yield junk bonds are not muni bonds.Portfolio protection from munis.The best place to put your bonds.
Upvote Downvote

 
Munis: 'Fed' And Fed Up?

2015-11-29 seekingalpha
In the wake of newly released economic indicators, namely large employment gains versus expectations, and the strong suggestion in the Federal Reserve’s (the “Fed’s”) commentar
Upvote Downvote

 
Are Yields On Treasuries And Munis Trading Places Again?

2015-11-29 seekingalpha
Historically, municipal bonds offered a negative spread when compared to Treasuries. The relationship reversed from 2008, but a pattern similar to that of prior to 2008 has reappeared recently.Tax-exe
Upvote Downvote

 
Municipals rush to issue ahead of rate hike

2015-11-12 seekingalpha
There was a 20% jump in the number of requests for new municipal bond security identifiers, according to the CUSIP Issuance Trends Report - the first increase in five months.While the start of Q4 and
Upvote Downvote

 
2 More Tax-Free Muni Bond CEFs For The AMT-Free Investor

2015-10-22 seekingalpha
My recent coverage of national, tax-free municipal bond CEFs failed to take note of two funds from Deutsche Financial.These two funds are fully competitive with the rest of the category and deserve fu
Upvote Downvote

 
AMT-Free Muni-Bond CEFs: Portfolio Quality

2015-10-20 seekingalpha
This is a follow up to an article listing and describing all CEFs providing income free of all federal taxes, including alternate minimum tax or AMT.14 funds comprise the category.Portfolios vary for
Upvote Downvote

 
Tax-Free, Municipal-Bond CEFs: The AMT-Free Funds

2015-10-19 seekingalpha
Municipal Bond CEFs offer high levels of income free from federal taxes.Most funds in the category are subject to varying levels of AMT - Alternate Minimum Tax.Here I list 14 CEFs free from federal ta
Upvote Downvote

 
MSRB Reduces Transparency For Muni Bond Buyers

2015-10-08 seekingalpha
MSRB diminishes transparency for muni bond buyers.Recent rule change shifts burden to investors.Please see my extra comment after the article.
Upvote Downvote

 
Marilyn Cohen's Bond Smart Investing: Decimal Dust

2015-10-08 seekingalpha
By Marilyn Cohen, Envision Capital ManagementThe definition of decimal dust: The Federal Reserve raising short-term rates by .25 = 25 basis points = 25/100 = not a high enough interest rate increase t
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...